About ABL Europe
ABL Europe is a company based in Rockville (United States) founded in 1961 was acquired by Oxford BioMedica in December 2023. ABL Europe operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Oxford BioMedica
(Dec 04, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ABL Europe
Detailed funding history for ABL Europe
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ABL Europe
ABL Europe has secured backing from 1 investor. Prominent investors backing the company include OXB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Gene therapies for multiple diseases are developed via lentiviral systems.
|
Locked | Locked | Locked |
Investor details for ABL Europe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ABL Europe
Investment portfolio details for ABL Europe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ABL Europe
Detailed financials for ABL Europe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abl Europe Comparisons
Peer comparison for ABL Europe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ABL Europe
ABL Europe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of ABL Europe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abl Europe
Complete news archive for ABL Europe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABL Europe
ABL Europe was founded in 1961.
ABL Europe is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
ABL was established in 1961 and is based in Rockville, United States. Preclinical development services are delivered by the company within the biotechnology and pharmaceutical sectors. Operations encompass support for drug discovery, safety assessments, and early-stage testing. Expertise is applied across various therapeutic areas, with a domain indicating European outreach. Services are tailored for research organizations seeking regulatory-compliant preclinical solutions.
ABL Europe's top competitors include Emmes, Syneos Health and ClinChoice.
ABL Europe has 1 investor. Key investors include OXB.